Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) EBITDA Margin: 2020-2025

Historic EBITDA Margin for Sotera Health (SHC) over the last 6 years, with Sep 2025 value amounting to 10.02%.

  • Sotera Health's EBITDA Margin fell 322.00% to 10.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.74%, marking a year-over-year decrease of 64.00%. This contributed to the annual value of -6.47% for FY2024, which is 1270.00% down from last year.
  • Sotera Health's EBITDA Margin amounted to 10.02% in Q3 2025, which was down 66.92% from 30.28% recorded in Q2 2025.
  • Sotera Health's 5-year EBITDA Margin high stood at 30.28% for Q2 2025, and its period low was -104.29% during Q4 2022.
  • For the 3-year period, Sotera Health's EBITDA Margin averaged around 3.54%, with its median value being 2.18% (2025).
  • As far as peak fluctuations go, Sotera Health's EBITDA Margin plummeted by 12,849bps in 2022, and later skyrocketed by 12,367bps in 2023.
  • Quarterly analysis of 5 years shows Sotera Health's EBITDA Margin stood at 24.20% in 2021, then tumbled by 12,849bps to -104.29% in 2022, then soared by 12,367bps to 19.38% in 2023, then plummeted by 4,396bps to -24.57% in 2024, then crashed by 322bps to 10.02% in 2025.
  • Its EBITDA Margin stands at 10.02% for Q3 2025, versus 30.28% for Q2 2025 and 2.18% for Q1 2025.